Intellectual Property Appellate Board

• 

  Facebook Posts Not Determinative Of A Person's Location: Delhi Court

  A court cannot treat Facebook posts as determinative of the location of a person at a particular point of time, the Delhi High Court has said, while allowing the plea of a lawyer against an order of the Intellectual Property Appellate Board (IPAB).

• Govt revokes GSK's patent on cancer drug in latest blow for big pharma

  India's patent appeals board has revoked a patent granted to GlaxoSmithKline Plc's breast cancer drug Tykerb, which is a salt form of the original compound, lapatinib.

• Supreme Court backs generics in Novartis drug patent ruling

  India's Supreme Court rejected Monday a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect access to cheap generic drugs and save lives in developing nations.

• Natco Pharma to continue selling Bayer's cancer drug Nexavar, stock up 12%

  The Intellectual Property Appellate Board (IPAB) on Monday upheld a decision to allow Natco Pharma to sell a generic version of Bayer AG's cancer drug Nexavar.

• Germany's Bayer vows to fight for anti-cancer drug patent in India

  German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.

• Patent board rules against Bayer in cancer drug case

  A patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.

• Indian board rejects AstraZeneca's patent plea on cancer drug

  India's patents appeal board has dismissed British drugmaker AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fighting drug, in the latest blow for Big Pharma in the country.

• Amul loses trademark case against US giant in Gujarat HC

  The Gujarat High Court has refused to set aside an order which cancelled Amul's registration of its trademark TRIX', on which a US firm has claimed its right. In July this year, the Intellectual Property Appellate Board had directed Registrar of Trademarks to cancel Amul's registration of TRIX trademark.

• Pfizer to appeal India decision to revoke cancer drug patent

  Pfizer Ltd, the India unit of U.S. drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug Sutent. The company, which will appeal before the Intellectual Property Appellate Board, said on Friday the Indian Patent Office's decision raised concerns over India's commitment to protect intellectual prop...